← Back to Search

Predictive Model Development for Hypoglycemia

N/A

Waitlist Available

Led By Matthew Gorris, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 90

Awards & highlights

Study Summary

This trial will create a model to predict diabetic episodes in patients on anti-hyperglycemic therapy, with the goal of developing a more accurate risk score.

Who is the study for?

This trial is for healthcare providers caring for adult patients (18+) on certain medical floors who are being treated with anti-hyperglycemic medications. It includes those working with the EndoTool and risk score, as well as comparison groups without these tools.Check my eligibility

What is being tested?

The study aims to develop a model that predicts low blood sugar events in diabetic inpatients using anti-hyperglycemic therapy. It will test the effectiveness of viewing this predictive risk score through an Electronic Health Record system.See study design

What are the potential side effects?

Since this trial involves standard care practices rather than new medications, there are no direct side effects from interventions being tested. However, managing glucose levels always carries risks like abnormal blood sugar levels.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 90

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 90

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 90 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

EndoTool Utilization Rates

Glucose Monitoring Team (GMT) Consult Utilization Rates

Inpatient hypoglycemia event rates

+1 more

Secondary outcome measures

Number of Inpatient hospitalizations with a hyperglycemic event

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: experimental hypoglycemia risk score is applied on a service which has already implemented EndoToolExperimental Treatment1 Intervention

Service where the experimental hypoglycemia risk score is applied on a service which has already implemented EndoTool

Group II: Standard of care glucose managementActive Control1 Intervention

Service which has not yet implemented EndoTool - providers adjusting insulin and consulting the Glucose Management Team at their discretion

Group III: Service where EndoTool is applied without the experimental hypoglycemia risk scoreActive Control1 Intervention

Service where EndoTool is applied without our experimental hypoglycemia risk score

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,240 Previous Clinical Trials

1,004,167 Total Patients Enrolled

Matthew Gorris, MDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

experimental hypoglycemia risk score is applied on a service which has already implemented EndoTool Clinical Trial Eligibility Overview. Trial Name: NCT05989256 — N/A

Hyperglycemic Therapy Research Study Groups: experimental hypoglycemia risk score is applied on a service which has already implemented EndoTool, Standard of care glucose management, Service where EndoTool is applied without the experimental hypoglycemia risk score

Hyperglycemic Therapy Clinical Trial 2023: experimental hypoglycemia risk score is applied on a service which has already implemented EndoTool Highlights & Side Effects. Trial Name: NCT05989256 — N/A

experimental hypoglycemia risk score is applied on a service which has already implemented EndoTool 2023 Treatment Timeline for Medical Study. Trial Name: NCT05989256 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial currently have any open spots for participants?

"According to the clinicaltrials.gov website, this particular trial is no longer accepting applications. Initially posted on October 1st 2023 and last updated on August 2nd 2023, it has since been superseded by one other study that currently requires participants for its research efforts."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Developing a Model to Predict Inpatient Hypoglycemic Episodes

2024. "Developing a Model to Predict Inpatient Hypoglycemic Episodes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05989256.

All > Hypoglycemia > Diabetes